IVOG β€” VANGUARD S&P MID-CAP 400 GRO

Ownership history in CITADEL ADVISORS LLC  Β·  26 quarters on record

This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in VANGUARD S&P MID-CAP 400 GRO (IVOG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

CITADEL ADVISORS LLC Γ— IVOG AI Analytics

πŸ“‰ CITADEL ADVISORS LLC underperformed the S&P 500 by –6.0% annually on this IVOG position. Timing score: 48% (12/25 decisions correct). Average cost basis: $72.97. Maximum drawdown during holding period: –25.6%.

πŸ“ˆ Position Alpha vs SPY
-6.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 6.0% ann.
25 quarters analyzed

⏱️ Timing Score
48%

➑️ Neutral timing β€” roughly coin-flip accuracy on add/trim calls.
12 of 25 add/trim decisions correct

πŸ’° Entry Quality
$72.97
+62.7% vs current ($118.72)

Best entry: $45.26 (2015 Q4)  Β·  Worst: $118.72 (2025 Q3)

πŸ›‘οΈ Drawdown Resilience
–25.6%
max drawdown while held

πŸ’ͺ Held through 2 major drawdowns (>20%).

πŸ’ͺ Fund Conviction
50%
buy-side decisions

13 adds Β· 13 trims. Bought during 4 of 8 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    IVOG price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 15,961 +10,667 +201.5% 0.00% $1.9M $118.72
2025 Q2 REDUCED 5,294 -15,081 -74.0% 0.00% $598K $112.31
2025 Q1 ADDED 20,375 +11,768 +136.7% 0.00% $2.1M $102.52
2024 Q3 ADDED 8,607 +6,061 +238.1% 0.00% $987K $113.02
2023 Q3 REDUCED 2,546 -2,929 -53.5% 0.00% $230K $88.02
2023 Q2 REDUCED 5,475 -8,795 -61.6% 0.00% $512K $91.14
2023 Q1 REDUCED 14,270 -5,113 -26.4% 0.00% $1.3M $86.61
2022 Q4 ADDED 19,383 +2,113 +12.2% 0.00% $3.3M $82.53
2022 Q3 ADDED 17,270 +13,061 +310.3% 0.00% $2.7M $75.89
2022 Q1 REDUCED 4,209 -17,416 -80.5% 0.00% $810K $92.77
16 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding IVOG

As of 2025 Q4 β€” sorted by position size

Stordahl Capital Management, Inc. 3Y 7Y 3.58% STEPHEN J. GARRY & ASSOCIATES, LLC 3.5% CLARK FINANCIAL SERVICES GROUP INC /BD 3Y 2.36% LJI Wealth Management, LLC 2.15% ESG Planning DBA Harper Investing 3Y 1.85% Integrated Capital Management, LLC 1.65% Octavia Wealth Advisors, LLC 3Y 1.54% VANTAGEPOINT INVESTMENT ADVISERS LLC 3Y 7Y 1.51% Baron Wealth Management LLC 1.08% Drucker Wealth 3.0, LLC 0.77%
← Back to CITADEL ADVISORS LLC Holdings